On May 13, 2016, Bio-Rad Laboratories, Inc. (“Plaintiff”) filed a complaint against Thermo Fisher Scientific, Inc. (“Defendant”), asserting infringement of U.S. Patent No. 8,236,504 (“the ‘504 Patent”). The ‘504 Patent is assigned to the Plaintiff and is drawn to systems and methods for fluorescence detection with a movable detection module. The Plaintiff is asserting that the Defendant is infringing the ‘504 Patent by making, using, selling, and/or offering to sell PCR systems, including the StepOne™ and StepOnePlus™ PCR systems of the Defendant. The case remains pending and is captioned 1-16-cv-00358.
By: Jacqueline A. DiRamio